DalsnaFinance › IPOs › Immix Biopharma › IPO
Immix Biopharma, Inc. completed its initial public offering on NASDAQ on December 16, 2021, pricing at $5.00 a share.
| Ticker | IMMX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | December 16, 2021 |
| Offering price | $5.00 |
| Shares offered | 4,200,000 |
| Total raised | $21M |
Immix Biopharma, Inc. sold 4,200,000 shares at $5.00 each on NASDAQ. Multiplied out, that is $21 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $21 million total recorded for the deal.
Immix Biopharma, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Immix Biopharma, Inc.. This page is general information, not investment advice.